{
  "Symbol": "RMD",
  "AssetType": "Common Stock",
  "Name": "ResMed Inc",
  "Description": "ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.",
  "CIK": "943819",
  "Exchange": "NYSE",
  "Currency": "USD",
  "Country": "USA",
  "Sector": "LIFE SCIENCES",
  "Industry": "SURGICAL & MEDICAL INSTRUMENTS & APPARATUS",
  "Address": "9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, US",
  "OfficialSite": "https://www.resmed.com",
  "FiscalYearEnd": "June",
  "LatestQuarter": "2024-12-31",
  "MarketCapitalization": "31269491000",
  "EBITDA": "1712289000",
  "PERatio": "24.87",
  "PEGRatio": "1.371",
  "BookValue": "35.77",
  "DividendPerShare": "2.02",
  "DividendYield": "0.0101",
  "EPS": "8.48",
  "RevenuePerShareTTM": "33.54",
  "ProfitMargin": "0.254",
  "OperatingMarginTTM": "0.325",
  "ReturnOnAssetsTTM": "0.139",
  "ReturnOnEquityTTM": "0.257",
  "RevenueTTM": "4926773000",
  "GrossProfitTTM": "2907906000",
  "DilutedEPSTTM": "8.48",
  "QuarterlyEarningsGrowthYOY": "0.649",
  "QuarterlyRevenueGrowthYOY": "0.103",
  "AnalystTargetPrice": "265.42",
  "AnalystRatingStrongBuy": "4",
  "AnalystRatingBuy": "8",
  "AnalystRatingHold": "6",
  "AnalystRatingSell": "1",
  "AnalystRatingStrongSell": "0",
  "TrailingPE": "24.87",
  "ForwardPE": "20.58",
  "PriceToSalesRatioTTM": "6.35",
  "PriceToBookRatio": "5.9",
  "EVToRevenue": "6.35",
  "EVToEBITDA": "18.34",
  "Beta": "0.755",
  "52WeekHigh": "262.46",
  "52WeekLow": "177.39",
  "50DayMovingAverage": "224.31",
  "200DayMovingAverage": "231.64",
  "SharesOutstanding": "146867000",
  "DividendDate": "2025-03-20",
  "ExDividendDate": "2025-02-13",
  "Last Updated": "2025-04-23 14:46:03",
  "Price_Day_1": 214.08,
  "Price_Day_2": 210.87,
  "Price_Day_3": 212.91,
  "Price_Day_4": 211.49,
  "Price_Day_5": 213.97,
  "Price_Day_6": 214.53,
  "Price_Day_7": 213.99,
  "Income_totalRevenue_Q1": "1282089000",
  "Income_grossProfit_Q1": "751275000",
  "Income_netIncome_Q1": "344622000",
  "Income_totalRevenue_Q2": "1224509000",
  "Income_grossProfit_Q2": "717219000",
  "Income_netIncome_Q2": "311355000",
  "Income_totalRevenue_Q3": "1223195000",
  "Income_grossProfit_Q3": "704265001",
  "Income_netIncome_Q3": "292236000",
  "Income_totalRevenue_Q4": "1196980000",
  "Income_grossProfit_Q4": "681577000",
  "Income_netIncome_Q4": "300492000",
  "Balance_totalAssets_Q1": "7141334000",
  "Balance_totalLiabilities_Q1": "1888325000",
  "Balance_totalShareholderEquity_Q1": "5253009000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q1": "521944000",
  "Balance_totalAssets_Q2": "7222417000",
  "Balance_totalLiabilities_Q2": "2027391000",
  "Balance_totalShareholderEquity_Q2": "5195026000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q2": "426361000",
  "Balance_totalAssets_Q3": "6872394000",
  "Balance_totalLiabilities_Q3": "2008351000",
  "Balance_totalShareholderEquity_Q3": "4864043000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q3": "238361000",
  "Balance_totalAssets_Q4": "6814562000",
  "Balance_totalLiabilities_Q4": "2184642000",
  "Balance_totalShareholderEquity_Q4": "4629920000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q4": "237910000",
  "Debt to Equity Ratio": 0.36,
  "Is Complete": true
}